MDxHealth grants CCO options at $0.76 strike
MDxHealth SA granted Chief Commercial Officer John Bellano a total of share options covering ordinary shares at an exercise price of $0.76 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MDxHealth SA granted Chief Commercial Officer John Bellano a total of share options covering ordinary shares at an exercise price of $0.76 per share. One grant of 217,000 options vests based on Company performance criteria, while a separate 116,000-option grant vests in three equal annual installments from the grant date.
Insider Trade Summary
Grant/Award: 333,000 shares
Grant/Award
2 txns
Insider
Bellano John
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option | 116,000 | $0.00 | $0.00 |
| Grant/Award | Share Option | 217,000 | $0.00 | $0.00 |
Holdings After Transaction:
Share Option — 333,000 contracts (Direct)
Footnotes (2)
- F1. Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026. The options vest upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
- F2. Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026 . The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Key Figures
Performance-based options granted: 217,000 options
Time-based options granted: 116,000 options
Exercise price: $0.76 per share
+3 more
6 metrics
Performance-based options granted
217,000 options
Share options with performance-criteria vesting granted on June 1, 2026
Time-based options granted
116,000 options
Share options vesting in three equal annual installments from June 1, 2026
Exercise price
$0.76 per share
Exercise price for both MDxHealth option grants
Combined option grants
333,000 options
Derived sum of 217,000 and 116,000 options granted to John Bellano
Option expiration date
May 28, 2036
Scheduled expiration for both sets of granted options
Transaction price per option
$0.00
Reported transaction price per share option in the grants
Key Terms
Share Option, exercise price, performance criteria, vest in three equal installments, +1 more
5 terms
exercise price financial
"options to purchase ordinary shares at a price per share of $0.76"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
performance criteria financial
"The options vest upon the achievement of certain Company performance criteria evaluated by the Board"
vest in three equal installments financial
"The options vest in three equal installments on each of the first three anniversaries"
expiration date financial
"expiration_date": "2036-05-28T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MDXH Chief Commercial Officer John Bellano receive in this Form 4 filing?
John Bellano received two grants of share options to acquire MDxHealth ordinary shares. One grant covers 217,000 options and another 116,000 options, both with an exercise price of $0.76 per share and different vesting conditions.
What are the vesting conditions for John Bellano's MDXH performance-based options?
The 217,000 MDxHealth share options vest only if certain Company performance criteria are achieved. These criteria are evaluated by the Board of Directors at the end of the relevant performance periods, tying vesting directly to the Company’s measured operating results.
How do the time-based MDXH options granted to John Bellano vest?
The 116,000 time-based MDxHealth share options vest in three equal installments. Vesting occurs on each of the first three anniversaries of the June 1, 2026 grant date, rewarding continued service over that three-year period.
What is the exercise price and expiration date of John Bellano’s MDXH options?
Both MDxHealth option grants to John Bellano carry an exercise price of $0.76 per ordinary share. According to the filing, these options are scheduled to expire on May 28, 2036, providing a long-term window for potential exercise.
Are John Bellano’s MDXH option grants open-market purchases or compensation awards?
These MDxHealth option grants are classified as awards under transaction code “A,” described as a grant, award, or other acquisition. The transaction price per option is reported as $0.00, indicating compensation-related awards rather than open-market purchases.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates